CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-06 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +15,285 | 40,992 | ||
| 2024-01-06 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −4,487 | $20.40 | $92K | 36,505 |
| 2024-01-06 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −15,285 | 30,570 | ||
| 2024-01-06 | Lurker Nancy Executive Vice Chair | Option exercise | +75,133 | 193,484 | ||
| 2024-01-06 | Lurker Nancy Executive Vice Chair | Shares withheld for taxes | −23,043 | $20.40 | $470K | 170,441 |
| 2024-01-06 | Lurker Nancy Executive Vice Chair | Option exercise · Restricted Stock Units | −75,133 | 150,267 | ||
| 2024-01-06 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Option exercise | +15,285 | 19,628 | ||
| 2024-01-06 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Shares withheld for taxes | −5,966 | $20.40 | $122K | 13,662 |
| 2024-01-06 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Option exercise · Restricted Stock Units | −15,285 | 30,570 | ||
| 2024-01-06 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +15,285 | 42,109 | ||
| 2024-01-06 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −4,147 | $20.40 | $85K | 37,962 |
| 2024-01-06 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −15,285 | 30,570 | ||
| 2024-01-06 | Duker Jay S. President and CEO | Option exercise | +20,793 | 50,014 | ||
| 2024-01-06 | Duker Jay S. President and CEO | Shares withheld for taxes | −6,528 | $20.40 | $133K | 43,486 |
| 2024-01-06 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −20,793 | 41,587 | ||
| 2024-01-06 | Elston George Chief Financial Officer | Option exercise | +15,285 | 40,219 | ||
| 2024-01-06 | Elston George Chief Financial Officer | Shares withheld for taxes | −4,911 | $20.40 | $100K | 35,308 |
| 2024-01-06 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −15,285 | 30,570 | ||
| 2024-01-05 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Restricted Stock Units | +21,000 | 21,000 | ||
| 2024-01-05 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 |
Page 17 of 18 · 352 trades